Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC1654 D2aak1

Novel dopamine D2 receptor antagonist as a potent multi-target ligand of aminergic G protein-coupled receptors (GPCRs) which dose-dependently stimulates growth, survival of neurons, and promotes their integrity

1797774-41-4
DCC1655 D2r Agonist Rel-trans-16b

Novel potent and selective agonist of dopamine D 2 receptor (D 2 R; K i = 4.58 nM)

DCC1656 D3r Agonist Rel-cis-14a

Novel potent and selective agonist of dopamine D 3 receptor (D 3 R; Ki = 5.72 nM)

DCC1657 D483-1785

Novel ERK2 inhibitor

DCC1658 D561-0775

Novel direct AMPK agonist, showing potential anti-cancer activity via inducing apoptosis, cell cycle arrest, suppressing glycolysis and cholesterol synthesis after activation of AMPK in gefitinib-resistant H1975 cells

1112400-30-2
DCC1659 D-87503

Novel dual extracellular signaling-related kinase (ERK)/PI3K inhibitor

800394-83-6
DCC1660 Da-6886

Novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice

1645260-76-9
DCC1661 Daam-3

Novel inhibitor of SET7/9

DCC1662 Dab-boro-nle

Novel selective and potent DPP7 inhibitor with a DPP7 IC50 value of 480 pM

DCC1663 Dab-pip Bis-tfa Salt

Selective inhibitor of human DPP7

620947-65-1
DCC1664 Daf-2-da

Widely used fluorescent detector of nitric oxide in culture medium, tissue sections and biopsy cells

205391-02-2
DCC1665 Dan004

Novel potent Bax inhibitor, showing concentration-dependent inhibition of liposome permeabilization with improved activity in vitro

DCC1666 Danicalipin A

Lipid bilayer modulator which likely inserts into lipid bilayers in the headgroup region, alters their structure and phase behavior, thins the bilayer and fluidizes it, allowing even saturated lipid to form fluid bilayers

DCC1667 Dansyl-neca

Potent and selective fluorescent adenosine A1 receptor agonist

219982-12-4
DCC1668 Dapl-in-1

Novel inhibitor of L,L-diaminopimelate aminotransferase (DapL)

423732-11-0
DCC1669 Dapoxetine

Potent Selective serotonin reuptake inhibitor (SSRI)

119356-77-3
DCC1670 Darapladib-impurity

An impurity formed in Darapladib production

1389264-17-8
DCC1671 Das-6-2-2-6-crbn

Proteolysis targeting chimeras (PROTAC), acting as a degrader of oncogenic BCR-ABL

1835705-47-9
DCC1672 Das-6-2-2-6-vhl

Proteolysis targeting chimeras (PROTAC), acting as a degrader of oncogenic BCR-ABL

DCC1673 Das-iap

Novel PROTAC targeting drug-resistant BCR-ABL

2222354-29-0
DCC1674 Dasiglucagon

Novel glucagon analog for diabetic hypoglycemia therapy

1544300-84-6
DCC1675 Dasolampanel Etibutil

Novel selective ionotropic glutamate receptor 5 (iGluR5) antagonist

503291-52-9
Page 1297 / Total 1557 FirstPrevNextLastGoto